# Cancer Patient Empowerment Program: Phase 2 Feasibility Study

> **NCT05508412** · NA · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 104 (actual)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** CancerPEP

## Key facts

- **NCT ID:** NCT05508412
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-06
- **Primary completion:** 2025-04-13
- **Final completion:** 2025-04-13
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508412, "Cancer Patient Empowerment Program: Phase 2 Feasibility Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05508412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*